Skip to Main Content

Paper Details

Longitudinal stability of molecular alterations and drug response profiles in tumor spheroid cell lines enables reproducible analyses.
Biomed Pharmacother
4
2021
glioblastoma, glioblastoma spheroid cell line models, glioblastoma spheroid models, patient, patient-derived tumor cell lines, predictive gene signatures, tumor, tumor spheroid cell lines
Author NameAffiliation
Daniel PicardHematology and Clinical Immunology, University Hospital Dusseldorf and Medical Faculty, Heinrich Heine University Dusseldorf, Germany Institute of Neuropathology, Germany German Cancer Research Center (DKFZ)
Nan QinHematology and Clinical Immunology, University Hospital Dusseldorf and Medical Faculty, Heinrich Heine University Dusseldorf, Germany Institute of Neuropathology, Germany German Cancer Research Center (DKFZ)
Marietta WolterInstitute of Neuropathology, University Hospital Dusseldorf and Medical Faculty, Heinrich Heine University Dusseldorf
David PauckHematology and Clinical Immunology, University Hospital Dusseldorf and Medical Faculty, Heinrich Heine University Dusseldorf, Germany Institute of Neuropathology
Viktoria MarquardtHematology and Clinical Immunology, University Hospital Dusseldorf and Medical Faculty, Heinrich Heine University Dusseldorf, Germany Institute of Neuropathology
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University
Marc RemkeHematology and Clinical Immunology, University Hospital Dusseldorf and Medical Faculty, Heinrich Heine University Dusseldorf, Germany Institute of Neuropathology, Germany German Cancer Research Center (DKFZ)
Guido ReifenbergerInstitute of Neuropathology, University Hospital Dusseldorf and Medical Faculty, Heinrich Heine University Dusseldorf, Germany German Cancer Research Center (DKFZ)
  • 1 - 9

Datasets

Release 1.2